Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

FLKS

FLEX PHARMA, INC. (FLKS)

Flex Pharma, Inc.
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:FLKS
日付受信時刻ニュースソース見出しコード企業名
2019/11/1306 : 35Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FLKSFlex Pharma, Inc.
2019/10/2821 : 33Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:FLKSFlex Pharma, Inc.
2019/10/2821 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLKSFlex Pharma, Inc.
2019/10/2305 : 23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLKSFlex Pharma, Inc.
2019/09/1906 : 03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FLKSFlex Pharma, Inc.
2019/09/1905 : 56Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:FLKSFlex Pharma, Inc.
2019/09/1706 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLKSFlex Pharma, Inc.
2019/09/1407 : 32Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:FLKSFlex Pharma, Inc.
2019/09/1407 : 31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:FLKSFlex Pharma, Inc.
2019/09/1319 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLKSFlex Pharma, Inc.
2019/09/1319 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLKSFlex Pharma, Inc.
2019/09/1319 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLKSFlex Pharma, Inc.
2019/08/1221 : 17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/3006 : 28Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/3006 : 28Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/3006 : 09Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/2505 : 49Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/2408 : 54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/2408 : 54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/2408 : 53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/2408 : 50Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/2408 : 49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/2306 : 09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/1906 : 06Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/1806 : 03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/1605 : 18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/1605 : 16Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/1305 : 16Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLKSFlex Pharma, Inc.
2019/07/1305 : 05Business WireFlex Pharma Announces Approval of all Merger-Related Proposals at Special MeetingNASDAQ:FLKSFlex Pharma, Inc.
2019/07/0204 : 04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLKSFlex Pharma, Inc.
 Showing the most relevant articles for your search:NASDAQ:FLKS